Although we did not find that amyloid deposition correlated with cognitive impairments, the results reinforce that SGLT-2 inhibition may be an attractive mechanism to improve cognition (31, 59, 60) as well as proteostasis under conditions of a high amyloid burden (33, 61). The gene discussed is SLC5A2; the disease is Cognitive impairment.